Bavarian Nordic Stock
StockStockPrice
Frequently asked questions
What is Bavarian Nordic's market capitalization?
What is Bavarian Nordic's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Bavarian Nordic?
What are the analyst ratings and target price for Bavarian Nordic's stock?
What is Bavarian Nordic's revenue over the trailing twelve months?
What is the EBITDA for Bavarian Nordic?
What is the free cash flow of Bavarian Nordic?
What is the 5-year beta of Bavarian Nordic's stock?
How many employees does Bavarian Nordic have, and what sector and industry does it belong to?
What is the free float of Bavarian Nordic's shares?
Financials
Market Cap
$2.30B5Y beta
1.69EPS (TTM)
$1.289Free Float
78.79MP/E ratio (TTM)
22.67Revenue (TTM)
$865.51MEBITDA (TTM)
$468.54MFree Cashflow (TTM)
$125.54MPricing
Analyst Ratings
The price target is $38.03 and the stock is covered by 7 analysts.
Buy
6
Hold
1
Sell
0
Information
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.
1,381
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker